Jpmorgan Chase & CO Denali Therapeutics Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 235,386 shares of DNLI stock, worth $5.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

235,386

Previous 221,062 6.48%

Holding current value

$5.81 Million

Previous $5.13 Million 33.57%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$20.96 - $31.05 $300,231 - $444,760	14,324 Added 6.48%	235,386 $6.86 Million
Q2 2024 Aug 12, 2024	BUY	$14.96 - $23.22 $1.23 Million - $1.91 Million	82,122 Added 59.11%	221,062 $5.13 Million
Q1 2024 May 10, 2024	SELL	$15.83 - $23.35 $702,472 - $1.04 Million	-44,376 Reduced 24.21%	138,940 $2.85 Million
Q4 2023 Feb 12, 2024	BUY	$16.2 - $23.18 $248,702 - $355,859	15,352 Added 9.14%	183,316 $3.93 Million
Q3 2023 Nov 14, 2023	BUY	$20.63 - $30.17 $205,722 - $300,855	9,972 Added 6.31%	167,964 $3.47 Million
Q2 2023 Aug 11, 2023	BUY	$23.37 - $32.96 $280,556 - $395,684	12,005 Added 8.22%	157,992 $4.66 Million
Q1 2023 May 18, 2023	BUY	$21.91 - $32.67 $3.17 Million - $4.73 Million	144,879 Added 13075.72%	145,987 $3.36 Million
Q1 2023 May 11, 2023	SELL	$21.91 - $32.67 $4.01 Million - $5.97 Million	-182,868 Reduced 99.4%	1,108 $25,000
Q4 2022 Feb 13, 2023	BUY	$26.28 - $33.92 $1.99 Million - $2.57 Million	75,622 Added 69.79%	183,976 $5.12 Million
Q3 2022 Nov 14, 2022	BUY	$25.97 - $38.53 $216,304 - $320,916	8,329 Added 8.33%	108,354 $3.33 Million
Q2 2022 Aug 11, 2022	BUY	$20.88 - $35.19 $55,394 - $93,359	2,653 Added 2.72%	100,025 $2.94 Million
Q1 2022 May 11, 2022	BUY	$29.0 - $47.27 $412,583 - $672,510	14,227 Added 17.11%	97,372 $3.13 Million
Q4 2021 Feb 10, 2022	SELL	$42.59 - $55.02 $654,395 - $845,382	-15,365 Reduced 15.6%	83,145 $3.71 Million
Q3 2021 Nov 12, 2021	BUY	$48.48 - $78.23 $4.78 Million - $7.71 Million	98,510 New	98,510 $4.97 Million

Others Institutions Holding DNLI

# of Institutions

228

Shares Held

120M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.31B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Denali Therapeutics Inc. Transaction History